Sleep apnea and heart attacks: new study aims to predict danger
NCT ID NCT07398430
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 1200 people who have had a heart attack or unstable angina and also have sleep apnea. Researchers will collect blood, urine, and stool samples to understand how sleep apnea affects metabolism and heart risk. The goal is to build an AI-based tool to better predict future heart attacks or strokes in these patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate way to predict heart and brain events in people with both sleep apnea and acute coronary syndrome.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any therapy, and the model may not be accurate enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,200 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Hospitalized patients diagnosed with ACS at Beijing Hospital.
- Ages
-
18 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-85 years. * Diagnosed with ACS, including ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina. * Willing to participate and sign the informed consent form. Exclusion Criteria: * Cardiogenic shock or cardiac arrest. * Central sleep apnea or other types of sleep disordered breathing. * Previous or current treatment with continuous positive airway pressure. * Inability to complete polysomnography or invalid data. * Malignancy or life expectancy \< 1 year.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute coronary syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does concentrating change your breathing? study probes Brain-Breath link in opioid users
- Tailoring cardiac rehab to each heart: can personalized training speed recovery?
- Can software read sleep studies as well as a specialist?
- Smart mask aims to measure blood oxygen through your face
- Can a 20-Minute playlist calm a heart attack Patient's nerves?
- Monthly shot aims to quiet sleep apnea and shed pounds